Unity Biotechnology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

Unity Biotechnology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

Unity Biotechnology, Inc. reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 97.29% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2025-03-07

• Unity Biotechnology, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2024 was 97.29%, a 3.38% increase from fiscal 2023.
• Unity Biotechnology, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2023 was 94.11%, a 9.15% increase from fiscal 2022.
• Unity Biotechnology, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2022 was 86.22%, a 0.61% increase from fiscal 2021.
• Unity Biotechnology, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2021 was 85.70%, a 7.45% decline from fiscal 2020.